Traditional Chinese Medicine Based on Zheng Differentiation versus Angiotensin Receptor Bl

Traditional Chinese Medicine Based on Zheng Differentiation versus Angiotensin Receptor Blocker/Angiotensin-converting Enzyme Antagonist in Efficacy of Treating Diabetic Kidney Disease: A Meta-analysis of Randomized Clinical

Trials

Wei-Jun Huang[1];Tao Yang[2];Chuan-Jiang Liu[2];Yong-Hua Xiao[2];Qiang Fu[2];Qing Gong[2];Hua Zhang[2];Fan Shao[2];Hong Yue[2];Shi-Dong Wang[2];Jin-Xi Zhao[2];

【期刊名称】《世界中医药杂志：英文版》 【年(卷),期】2019(005)001

【摘要】Objective: To compare the efficacy of traditional Chinese medicine (TCM) based on Zheng differentiation with angiotensin receptor blocker/angiotensin-converting enzyme inhibitor (ARB/ACEI) in treating diabetic kidney disease (DKD) from the aspects of decreasing urinary microalbumin, declining 24-h urinary protein, reducing endpoint events, and renal function protection. Methods: The Chinese Biomedical Literature Database (CBM), the Chinese Academy of Sciences database (CNKI), the VIP Chinese journal database, Wanfang DATA, Medline database, Cochrane library, excerpt medical database (Embase), and Web of scie nee were used for literature searchi ng. The reviewer man ager 5.3 software was utilized to analyze the data. Results: Twenty-four studies including 1956 participants were involved in this review. Results